These include the refinement of Ad vectors to improve their safety profile, the discovery of new AAV serotypes, the evolution of lipid nanoparticle (LNP) engineering, the discovery of CRISPR ...

While protein or AAV samples typically exhibit a smaller number of distinct species, LNP samples often exhibit a continuous distribution in size, molecular weight, and payload. Several physical ...

Adeno-associated virus (AAV) vectors are also being explored for ... will work with Vertex Pharmaceuticals to use Orna’s lipid nanoparticle (LNP) technology to develop next-generation in vivo ...

InnovecBio has two main delivery platforms: an adeno-associated virus (AAV) vector and a non-viral lipid nanoparticle (LNP) vector. InnovecBio has begun to secure the core patents for both ...